When patients were divided in two subgroups according to tumor grade of differentiation, we found statistically significant lower serum leptin levels only for patients with poorly differentiated tumors and mucinous adenocarcinoma, additionally suggesting a gradually decrease in leptin levels with tumor aggressiveness. Here, LEP is linked to neoplasm.